Search results
Moderna stock closes in green after eight sessions of losses (NASDAQ:MRNA)
Seeking Alpha· 2 weeks agoMaddie Meyer/Getty Images News Moderna (NASDAQ:MRNA) closed in green and snapped an eight-day losing...
Moderna stock gains on OpenAI deal (NASDAQ:MRNA)
Seeking Alpha· 2 weeks agoModerna (MRNA) stock gains as company announces a deal with AI company OpenAI to accelerate the development of new medicines. Read more here.
Moderna, Inc. (NASDAQ:MRNA) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 16 hours agoModerna, Inc. (NASDAQ:MRNA) Q1 2024 Earnings Call Transcript May 2, 2024 Moderna, Inc. beats...
Decoding Moderna Inc (MRNA): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 1 day agoIn conclusion, Moderna Inc (NASDAQ:MRNA) faces a challenging financial landscape marked by a...
Moderna (MRNA) Gears Up for Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 6 days agoInvestors' focus will likely be on updates on Moderna's (MRNA) expected RSV vaccine launch and its...
Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing
Zacks via Yahoo Finance· 1 week agoModerna (MRNA) closed the most recent trading day at $107.97, moving +1.69% from the previous...
Moderna to seek parity for RSV shot (NASDAQ:MRNA)
Seeking Alpha· 3 days agoModerna (MRNA) stock gains as the company highlights its upcoming RSV shot, expecting the U.S. regulators to endorse it on par with rival products. Read more here.
Analysts Estimate Moderna (MRNA) to Report a Decline in Earnings: What to Look Out for
Zacks· 1 week agoWall Street expects a year-over-year decline in earnings on lower revenues when Moderna (MRNA Quick QuoteMRNA - Free Report) reports results for the quarter ...
Smart Money Is Betting Big In MRNA Options - Moderna (NASDAQ:MRNA)
Benzinga· 5 days agoPrograms span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases. Where Is Moderna Standing Right ...
Moderna Breaks Out For The First Time In A Year After Covid Shot Wallops Sales Views
Investor's Business Daily· 2 days ago"It's our second product, so I think it helps validate the mRNA, or Moderna, platform. I think it's...